Angiopoietins as Targets for Diabetic Retinopathy Treatment

Diabetic eye diseases, such as diabetic retinopathy (DR) and diabetic macular edema (DME) are among the leading causes of blindness in developed countries. Anti-VEGF therapies such as, ranibizumab, aflibercept and off-label bevacizumab have become first-line treatment for DME. While randomized contr...

Descripción completa

Detalles Bibliográficos

Autores principales:	Ciulla, Lauren M., Patel, Nimesh A., Yannuzzi, Nicolas A., Hussain, Rehan M.
Formato:	Capítulo de libro
Lenguaje:	inglés
Publicado:	IntechOpen 2021
Materias:	Health Sciences
Acceso en línea:	https://www.intechopen.com/chapters/78191
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!